Health care resource utilization in untreated HIV-infected children in a pediatric programme, Abidjan, Côte d'Ivoire, 2004-2009

Journal of Acquired Immune Deficiency Syndromes

Volumn 62, Issue 1, 2013, Pages

  Desmonde, Sophie ^a,b   Coffie, Patrick A ^c   Aka, Edmond A ^d   Amani Bosse, Clarisse ^c,d   Messou, Eugène ^d   Dabis, François ^a,b   Ciaranello, Andrea ^e   Leroy, Valériane ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE TREICHVILLE   (Côte d’Ivoire)

^d ACONDA   (Côte d’Ivoire)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

health care resource utilization; HIV; morbidity; pediatrics; West Africa

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE;

ARTICLE; CHILD; CHILD HOSPITALIZATION; DEATH; FEMALE; FOLLOW UP; HEALTH CARE FACILITY; HEALTH CARE UTILIZATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MORBIDITY; OUTPATIENT CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; WORLD HEALTH ORGANIZATION;

ADOLESCENT; AMBULATORY CARE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COTE D'IVOIRE; FEMALE; HEALTH SERVICES; HIV INFECTIONS; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROSPECTIVE STUDIES;

EID: 84872075902     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182739c95     Document Type: Article

References (42)

1. Azcoaga-Lorenzo A, Ferreyra C, Alvarez A, et al. Effectiveness of a PMTCT programme in rural Western Kenya. AIDS Care. 2011;23:274-280.
2. Timité-Konan AM, Fassinou P, Adonis-Koffy L, et al. Use of antiretroviral drugs in HIV infected children in a tropical area: a real benefit. Archives De Pédiatrie. 2003;10:831-832.
3. Tonwe-Gold B, Ekouevi DK, Viho I, et al. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach. PLoS Med. 2007;4:e257.
4. World Health Organization. UNAIDS Report on the Global AIDS Epidemic, 2010. Geneva, Switzerland, UNAIDS, 2010.
5. Anaky MF, Duvignac J, Wemin L, et al. Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programme. Bull World Health Organ. 2010;88:490-499.
6. Coffie PA, Kanhon SK, Toure H, et al. Nevirapine for the prevention of mother-to-child transmission of HIV: a nation-wide coverage survey in Côte d'Ivoire. J Acquir Immune Defic Syndr. 2011;57:3-8.
7. Kids-ART-Linc-Collaboration. Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa. J Acquir Immune Defic Syndr. 2008;49:523-531.
8. World Health Organization. Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector. Progress Report 2010. Geneva, Switzerland, UNAIDS, 2010.
9. Stringer EM, Ekouevi DK, Coetzee D, et al. Coverage of nevirapinebased services to prevent mother-to-child HIV transmission in 4 African countries. JAMA. 2010;304:293-302.
10. Nielsen K, Bryson YJ. Diagnosis of HIV infection in children. Pediatr Clin North Am. 2000;47:39-63.
11. Desmonde S, Coffie P, Aka E, et al. Severe morbidity and mortality in untreated HIV-infected children in a paediatric care programme in Abidjan, Côte d'Ivoire, 2004-2009. BMC Infect Dis. 2011;11:182.
12. Harambat J, Fassinou P, Becquet R, et al. 18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire: a cohort study. BMC Public Health. 2008;8:169.
13. Lucas SB, Peacock CS, Hounnou A, et al. Disease in children infected with HIV in Abidjan, Côte d'Ivoire. BMJ. 1996;312:335-338.
14. Toure S, Kouadio B, Seyler C, et al. Rapid scaling-up of antiretroviral therapy in 10, 000 adults in Côte d'Ivoire: 2-year outcomes and determinants. AIDS. 2008;22:873-882.
15. de Cherif TKS, Schoeman JH, Cleary S, et al. Early severe morbidity and resource utilization in South African adults on antiretroviral therapy. BMC Infect Dis. 2009;9:205.
16. Sutcliffe CG, van Dijk JH, Bolton C, et al. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis. 2008;8:477-489.
17. Gona P, Van Dyke RB, Williams PL, et al. Incidence of opportunistic and other infections in HIV-infected children in the HAART era. JAMA. 2006;296:292-300.
18. World Health Organization. Antiretroviral Therapy for HIV Infection in Infants and Children: Towards Universal Access. Recommendations for a Public Health Approach. 2010 Revision. UNAIDS; 2010.
19. Ministry of Fight Against AIDS. Survey on HIV determinants in Côte d'Ivoire (EIS-CI). Abidjan; 1997.
20. Ministry of Fight Against AIDS. HIV sentinel serosurveillance in pregnant women in Côte d'Ivoire. Survey Report; Abidjan, 2004.
21. Ekouevi DK, Stringer E, Coetzee D, et al. Health facility characteristics and their relationship to coverage of PMTCT of HIV services across four African Countries: The PEARL Study. PLoS One. 2012;7: e29823.
22. Tonwe-Gold B, Ekouevi DK, Bosse CA, et al. Implementing familyfocused HIV care and treatment: the first 2 years' experience of the mother-to-child transmission-plus program in Abidjan, Côte d'Ivoire. Trop Med Int Health. 2009;14:204-212.
23. World Health Organization. WHO Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunological Classification of HIV-Related Disease in Adults and Children. Geneva, Switzerland: UNAIDS; 2007.
24. World Health Organization. Antiretroviral Therapy of HIV Infection in Infants and Children: Towards Universal Access. Recommendations for a Public Health Approach. Geneva, Switzerland: UNAIDS; 2006.
25. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics. 1988;44: 1049-1060.
26. World Health Organization. Guidelines on Co-Trimoxazole Prophylaxis for HIV-Related Infections Among Children, Adolescents and Adults. Recommendations for a Public Health Approach. Geneva, Switzerland: UNAIDS; 2006.
27. Imani PD, Musoke P, Byarugaba J, et al. Human immunodeficiency virus infection and cerebral malaria in children in Uganda: a case-control study. BMC Pediatr. 2011;11:5.
28. Walters E, Cotton MF, Rabie H, et al. Clinical presentation and outcome of tuberculosis in human immunodeficiency virus infected children on anti-retroviral therapy. BMC Pediatr. 2008;8:1.
29. Thea DM, St Louis ME, Atido U, et al. A prospective study of diarrhea and HIV-1 infection among 429 Zairian infants. N Engl J Med. 1993; 329:1696-1702.
30. Chintu C, Bhat GJ, Walker AS, et al. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet. 2004;364:1865-1871.
31. Mulenga V, Ford D, Walker AS, et al. Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children. AIDS. 2007;21:77-84.
32. Gasasira AF, Kamya MR, Ochong EO, et al. Effect of trimethoprimsulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance. Malar J. 2010; 9:177.
33. The Cross Continents Collaboration for Kids. Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis. AIDS. 2008;22:97-105.
34. Braitstein P, Songok J, Vreeman RC, et al. "Wamepotea" (they have become lost): outcomes of HIV-positive and HIV-exposed children lost to follow-up from a large HIV treatment program in western Kenya. J Acquir Immune Defic Syndr. 2011;57:e40-e46.
35. Donahue MC, Dube Q, Dow A, et al. "They have already thrown away their chicken": barriers affecting participation by HIV-infected women in care and treatment programs for their infants in Blantyre, Malawi. AIDS Care. 2012;24:1233-1239.
36. Hardon A, Vernooij E, Bongololo-Mbera G, et al. Women's views on consent, counseling and confidentiality in PMTCT: a mixed-methods study in four African countries. BMC Public Health. 2012;12:26.
37. 3Cs4Kids. Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis. AIDS. 2008;22: 97-105.
38. Walenda C, Kouakoussui A, Rouet F, et al. Morbidity in HIV-1-Infected children treated or not treated with highly active antiretroviral therapy (HAART), Abidjan, Cote d'Ivoire, 2000-04. J Trop Pediatr. 2009;55: 170-176.
39. Orne-Gliemann J, Becquet R, Ekouevi DK, et al. Children and HIV/AIDS: from research to policy and action in resource-limited settings. AIDS. 2008;22:797-805.
40. Bland RM. Management of HIV-infected children in Africa: progress and challenges. Arch Dis Child. 2011;96:911-915.
41. Haldar P, S Reddy DC. Challenges in providing HIV care to paediatric age group in India. Indian J Med Res. 2009;129:7-10.
42. Sansom SL, Anderson JE, Farnham PG, et al. Updated estimates of healthcare utilization and costs among perinatally HIV-infected children. J Acquir Immune Defic Syndr. 2006;41:521-526.